Guidance: FDA Weighs Risk-Benefit Factors When Making Device Enforcement Decisions

The GMP Letter
If the FDA conducts a benefit-risk assessment and finds the device has a high benefit to patients and the compliance issue causes little risk, it may decide to work with a company informally, rather than taking an official enforcement action.

To View This Article:


Subscribe To The GMP Letter